Drug Profile
Autologous cultured myoblasts and fibroblasts - Innovacell Biotechnologie
Alternative Names: UrocellLatest Information Update: 07 Jul 2008
Price :
$50
*
At a glance
- Originator Innovacell Biotechnologie GmbH
- Class Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Stress incontinence
Most Recent Events
- 31 Dec 2006 Launched for Stress incontinence in Belgium (Intravesicular)
- 31 Dec 2006 Launched for Stress incontinence in Germany (Intravesicular)
- 31 Dec 2006 Launched for Stress incontinence in Switzerland (Intravesicular)